Recombinant Yersinia pestis bv. Antiqua Phosphoserine aminotransferase (serC)

What is the genomic context of the serC gene in Y. pestis bv. Antiqua?

The serC gene in Y. pestis bv. Antiqua exists within a genome of approximately 4.7 Mb encoding 4,138 open reading frames . The genomic organization of Y. pestis Antiqua contains strain-specific rearrangements, insertions, deletions, and single nucleotide polymorphisms compared to other Y. pestis strains . When analyzing serC specifically, researchers should note that the gene exists within a complex genomic context that has been shaped by recent evolutionary processes as Y. pestis adapted from its ancestral Y. pseudotuberculosis lineage .

During genomic analysis, it's important to consider that Y. pestis genomes have undergone extensive rearrangements and contain numerous insertion sequence elements that must be excluded from consideration during single nucleotide polymorphism (SNP) analysis . The serC gene should be analyzed in context with other metabolic genes to understand potential functional relationships in amino acid biosynthesis pathways.

How does the serC gene differ between Y. pestis bv. Antiqua and other Y. pestis biovars?

While the search results don't provide specific details about serC variation between biovars, they do indicate that Y. pestis strains contain approximately 453 single nucleotide polymorphisms in protein-coding regions that can be used to assess evolutionary relationships between strains . The differentiation of biovars is traditionally based on biochemical assays, but genomic analysis has revealed that these classical definitions don't always accurately reflect phylogenetic relationships .

The biovars of Y. pestis are grouped according to their ability to reduce nitrate and use glycerol. Antiqua biovars are positive for both abilities, whereas Medievalis biovars do not reduce nitrate but are positive for glycerol utilization, and Orientalis reduce nitrate but do not utilize glycerol . These metabolic differences may influence the expression or function of metabolic enzymes like SerC across different biovars.

What is the function of phosphoserine aminotransferase (SerC) in Y. pestis metabolism?

The phosphoserine aminotransferase (SerC) in Y. pestis is an enzyme involved in serine biosynthesis, a critical amino acid pathway. While not explicitly described in the search results, SerC typically catalyzes the conversion of 3-phosphohydroxypyruvate to phosphoserine, which is a key step in serine biosynthesis. This pathway is essential for protein synthesis and cellular metabolism in bacteria.

In Y. pestis, which has undergone gene reduction during its evolution from Y. pseudotuberculosis, biosynthetic pathways have been selectively maintained or lost depending on their importance for survival in mammalian hosts and flea vectors . Understanding SerC function requires considering how Y. pestis balances amino acid acquisition from its host environment versus de novo synthesis, particularly as it transitions between different host environments during its lifecycle.

How does temperature affect the expression and activity of recombinant SerC from Y. pestis bv. Antiqua?

Research methodologies to study temperature-dependent SerC expression should include:

• Culturing Y. pestis bv. Antiqua at different temperatures (e.g., 28°C to mimic flea vector and 37°C to mimic mammalian host)

• RNA extraction and quantitative PCR to measure serC transcript levels

• Protein extraction and Western blotting to quantify SerC protein levels

• Enzyme activity assays under different temperature conditions

When comparing data between temperature conditions, researchers should consider that Y. pestis undergoes significant transcriptional reprogramming at different temperatures, which affects numerous metabolic pathways . The Yersiniomics database provides valuable resources for examining gene expression under different temperature conditions, which can serve as a model for studying serC expression .

What are the challenges in obtaining functionally active recombinant SerC from Y. pestis bv. Antiqua?

Obtaining functionally active recombinant SerC from Y. pestis bv. Antiqua presents several technical challenges:

• Expression system selection: While E. coli is commonly used for recombinant protein expression, structural differences between Y. pestis and E. coli proteins might affect proper folding. The search results mention that genomic DNA from Y. pestis strains can be cloned into vectors for amplification in E. coli , but protein expression systems require careful optimization.

• Protein solubility: Metabolic enzymes like SerC may form inclusion bodies when overexpressed, requiring optimization of expression conditions or solubilization strategies.

• Post-translational modifications: If SerC requires specific post-translational modifications for activity, these may not occur properly in heterologous expression systems.

• Biosafety considerations: Y. pestis is a biosafety level 3 organism , requiring appropriate containment facilities. Working with recombinant constructs derived from Y. pestis requires adherence to biosafety protocols, even when expressed in less pathogenic hosts.

Methodologically, researchers should consider using Y. pseudotuberculosis as an expression host for Y. pestis proteins, as demonstrated in research with other Y. pestis antigens . This closely related species shares many genetic features with Y. pestis but has reduced pathogenicity and biosafety requirements.

How can structural analysis of SerC contribute to understanding Y. pestis metabolic adaptation during infection?

Structural analysis of SerC can provide insights into Y. pestis metabolic adaptation during infection through several research approaches:

• Comparative structural biology: By resolving the three-dimensional structure of SerC from Y. pestis bv. Antiqua and comparing it with SerC from other Y. pestis biovars or Y. pseudotuberculosis, researchers can identify structural differences that may explain metabolic adaptations.

• Substrate binding analysis: Determining how SerC interacts with its substrates can reveal adaptations in catalytic efficiency or substrate specificity that might benefit Y. pestis during infection.

• Temperature-dependent structural changes: As Y. pestis transitions between flea vector (lower temperature) and mammalian host (higher temperature), proteins may undergo conformational changes. Structural studies at different temperatures can reveal these adaptations.

• Protein-protein interaction networks: Identifying proteins that interact with SerC can place it within the broader context of metabolic networks in Y. pestis, particularly those that change during host adaptation.

Y. pestis has undergone gene reduction during its evolution, with many inactivations likely related to the organism's interaction with its host environment . Structural studies of remaining metabolic enzymes like SerC can help explain why certain pathways have been retained while others were lost during this evolutionary process.

What are the optimal conditions for cloning and expressing recombinant SerC from Y. pestis bv. Antiqua?

Based on methodologies used for Y. pestis genomic work, the following approach is recommended for cloning and expressing recombinant SerC:

• DNA source: Genomic DNA should be isolated from Y. pestis strain Antiqua under appropriate biosafety conditions . PCR amplification of the serC gene should use high-fidelity polymerase to minimize mutation introduction.

• Cloning vectors: The serC gene can be cloned into expression vectors like pUC18 for initial amplification in E. coli . For protein expression, vectors with inducible promoters (e.g., T7 or arabinose-inducible systems) are recommended.

• Expression host: While E. coli is commonly used, consider Y. pseudotuberculosis expression systems for more native-like post-translational processing, as demonstrated in other Y. pestis protein studies .

• Expression conditions:

  • Temperature: 28-30°C (optimal for Y. pestis growth)

  • Induction: Gentle induction with lower inducer concentrations may improve soluble protein yield

  • Growth media: Rich media like heart infusion broth (HIB) supports robust growth of Yersinia species

• Protein purification: Affinity tags (His-tag, GST) can facilitate purification, but consider native purification methods if tags affect enzyme activity.

The biosafety considerations are crucial when working with Y. pestis-derived constructs. The American Society for Microbiology suggests biosafety level 2 practices including a biosafety cabinet as the minimum requirement for safe handling of diagnostic samples, while Y. pestis itself requires biosafety level 3 practices .

What analytical methods are most effective for assessing recombinant SerC activity?

To effectively assess recombinant SerC activity from Y. pestis bv. Antiqua, a multi-faceted analytical approach is recommended:

• Spectrophotometric enzyme assays: The phosphoserine aminotransferase activity can be measured by coupled enzyme assays that monitor the production of phosphoserine from 3-phosphohydroxypyruvate.

• HPLC analysis: High-performance liquid chromatography can be used to separate and quantify reaction substrates and products for more precise activity measurements.

• Isothermal titration calorimetry (ITC): This technique can determine binding constants for substrates and cofactors, providing insights into the enzyme's kinetic properties.

• Differential scanning fluorimetry: This method can assess thermal stability of the enzyme under different conditions, which is particularly relevant given Y. pestis' adaptation to different temperature environments.

• Activity under different pH conditions: As Y. pestis encounters different pH environments during infection, testing SerC activity across a pH range (especially pH 7.4, which is optimal for Y. pestis growth) is important .

When analyzing activity data, researchers should compare results with metabolic enzymes from other Y. pestis strains and Y. pseudotuberculosis to identify any biovar-specific adaptations that might reflect the unique ecological niche of the Antiqua biovar.

How can transcriptomic and proteomic approaches be integrated to study SerC regulation in Y. pestis bv. Antiqua?

Integration of transcriptomic and proteomic approaches provides a comprehensive understanding of SerC regulation in Y. pestis bv. Antiqua:

• RNA-Seq analysis: The Yersiniomics database demonstrates the value of RNA-Seq for studying gene expression in Yersinia species under different conditions . For SerC, RNA-Seq can identify:

  • Temperature-dependent expression changes

  • Co-expression with other metabolic genes

  • Regulatory elements affecting transcription

• Quantitative proteomics: Mass spectrometry-based proteomics can quantify SerC protein levels and identify post-translational modifications that might regulate activity.

• Integration strategies:

  • Compare transcript and protein abundance to identify post-transcriptional regulation

  • Use clustering analysis to identify genes with similar expression patterns

  • Apply principal component analysis to visualize relationships between different experimental conditions, as demonstrated in the Yersiniomics platform

• Experimental design considerations:

  • Include multiple biological replicates (minimum 3) for statistical validity

  • Test multiple environmental conditions relevant to Y. pestis lifecycle

  • Include appropriate controls for normalization of both transcriptomic and proteomic data

The Yersiniomics platform provides a valuable resource for analyzing and visualizing such data, as it allows user-friendly navigation between genomic data, expression data, and experimental conditions . Interactive volcano plots can help identify significantly regulated genes like serC under different conditions, and hierarchical clustering can reveal relationships between different experimental conditions .

How should sequence variations in the serC gene between Y. pestis isolates be interpreted?

When analyzing sequence variations in the serC gene between Y. pestis isolates, researchers should consider the following interpretative framework:

• SNP significance assessment: The 453 single nucleotide polymorphisms identified in protein-coding regions across Y. pestis strains have been used to assess evolutionary relationships . For serC specifically, SNPs should be classified as:

  • Synonymous vs. non-synonymous mutations

  • Mutations affecting conserved catalytic residues vs. peripheral regions

  • Lineage-specific vs. randomly distributed mutations

• Evolutionary context: Y. pestis evolved from Y. pseudotuberculosis relatively recently and continues to evolve through genome rearrangements, insertions, deletions, and SNPs . SerC variations should be interpreted within this evolutionary framework.

• Functional implications: For non-synonymous mutations, structural modeling can predict effects on:

  • Protein stability

  • Substrate binding

  • Catalytic efficiency

  • Protein-protein interactions

• Biovar-specific adaptations: Antiqua biovars are positive for both nitrate reduction and glycerol utilization , which may correlate with specific serC sequence features that support these metabolic capabilities.

Comprehensive sequence analysis should include comparison with both other Y. pestis biovars and ancestral Y. pseudotuberculosis to distinguish mutations that occurred during species divergence from those that appeared later during biovar differentiation.

What computational tools are most appropriate for modeling SerC structure and predicting functional impacts of mutations?

For modeling SerC structure and predicting functional impacts of mutations in Y. pestis bv. Antiqua, the following computational approaches are recommended:

• Homology modeling tools:

  • SWISS-MODEL or Phyre2 for initial structure prediction based on homologous proteins

  • AlphaFold2 for more accurate ab initio structure prediction

  • Molecular dynamics simulations to refine models and assess flexibility

• Mutation impact prediction:

  • PROVEAN, PolyPhen-2, or SIFT for initial assessment of mutation severity

  • FoldX for calculating changes in protein stability

  • Molecular dynamics simulations to model structural perturbations

• Functional site prediction:

  • ConSurf for identifying evolutionarily conserved residues

  • CASTp for predicting binding pockets and active sites

  • Molecular docking (AutoDock, HADDOCK) to model substrate interactions

• Comparative analysis across strains:

  • Multiple sequence alignment tools (Clustal Omega, MUSCLE) to align SerC sequences

  • Phylogenetic analysis tools to place mutations in evolutionary context

  • The Yersiniomics platform for contextualizing findings with other genomic and transcriptomic data

When interpreting computational predictions, researchers should consider that Y. pestis genomes contain numerous insertion sequences and undergo frequent genome rearrangement events that cause continuous evolution . This dynamic genomic context may influence the functional impact of mutations beyond what can be predicted from protein structure alone.

How can experimental data on SerC be integrated with broader metabolic network analysis in Y. pestis?

Integrating SerC experimental data with broader metabolic network analysis in Y. pestis requires sophisticated approaches that connect individual enzyme function to system-level metabolism:

• Genome-scale metabolic modeling:

  • Construct a genome-scale metabolic model of Y. pestis bv. Antiqua including SerC reactions

  • Use flux balance analysis to predict metabolic flux distributions

  • Simulate serC mutations or knockouts to predict system-wide effects

• Integration with multi-omics data:

  • Overlay transcriptomic data on metabolic models to constrain reaction fluxes

  • Incorporate proteomic data to refine enzyme abundance constraints

  • Use metabolomic data to validate model predictions

• Comparative analysis across growth conditions:

  • Compare metabolic network states between flea-like (28°C) and mammalian host-like (37°C) conditions

  • Identify condition-specific metabolic modules that include SerC

  • Map differences in SerC activity to broader pathway changes

• Contextualizing with virulence mechanisms:

  • Analyze connections between serine metabolism and virulence factor production

  • Investigate potential metabolic bottlenecks affecting pathogenesis

  • Explore metabolic adaptations specific to the Antiqua biovar's ecological niche

The Yersiniomics platform can facilitate these integrative analyses by providing access to normalized, processed experimental data across multiple conditions and allowing interactive exploration of relationships between genes, proteins, and conditions . The platform's ability to generate interactive visualizations such as volcano plots and principal component analyses can help identify significant patterns in complex datasets .

How can recombinant SerC be used to develop new diagnostic tools for Y. pestis bv. Antiqua?

Recombinant SerC from Y. pestis bv. Antiqua could be leveraged to develop novel diagnostic approaches with several advantages over conventional methods:

• Serological diagnostics:

  • If SerC contains biovar-specific epitopes, it could be used in ELISA or lateral flow assays specifically targeting Antiqua strains

  • Recombinant SerC could serve as a positive control antigen in diagnostic assays

  • Anti-SerC antibodies could be developed for immunohistochemical detection in tissue samples

• Molecular diagnostics:

  • SerC-specific PCR primers targeting biovar-specific regions could improve detection specificity

  • Aptamer-based detection systems using SerC as a target could provide rapid field testing options

  • CRISPR-Cas diagnostic systems could be developed targeting serC gene sequences

• Metabolic activity-based detection:

  • Substrate analogs that interact with SerC could be developed as activity-based probes

  • Fluorogenic substrates for SerC could enable rapid enzymatic detection assays

When developing such diagnostic tools, researchers should consider that current gold standard for plague diagnosis is microbial isolation of the organism from patient samples, with direct fluorescent antibody, PCR, serological, and rapid diagnostic tests also available . New SerC-based diagnostics would need to demonstrate advantages over these established methods.

What insights can comparative analysis of SerC across Y. pestis biovars provide about plague evolution?

Comparative analysis of SerC across Y. pestis biovars can provide valuable insights into plague evolution:

• Evolutionary trajectory mapping:

  • SerC sequence analysis across the three classical biovars (Antiqua, Medievalis, and Orientalis) could reveal lineage-specific adaptations

  • Comparison with Y. pseudotuberculosis SerC can identify changes that occurred during the emergence of Y. pestis as a species

  • Analysis of SerC in "nonclassical" Y. pestis strains like the microtus biovar can reveal alternative evolutionary paths

• Structure-function relationships across phylogeny:

  • Correlating SerC structural changes with biovar-specific metabolic capabilities

  • Identifying conserved vs. variable regions that reflect evolutionary pressures

  • Mapping amino acid substitutions onto three-dimensional structures to visualize evolutionary patterns

• Metabolic adaptation signatures:

  • Linking SerC variations to known metabolic differences between biovars, such as nitrate reduction and glycerol utilization capabilities

  • Identifying potential co-evolution with other metabolic enzymes

  • Correlating SerC evolution with adaptation to different ecological niches and host species

The genomic data from Y. pestis strains Antiqua and Nepal516, representing separate lineages within the classical biovar antiqua, demonstrate that grouping Y. pestis strains based strictly on the classical definition of biovars (predicated upon two biochemical assays) does not accurately reflect the phylogenetic relationships within this species . This suggests that SerC evolutionary analysis could provide a more nuanced view of Y. pestis evolution than traditional biovar classifications.

How might recombinant SerC contribute to vaccine development against Y. pestis?

While SerC itself may not be an obvious vaccine antigen candidate, research on recombinant SerC could contribute to plague vaccine development in several ways:

• Understanding metabolic requirements during infection:

  • Characterizing SerC's role in Y. pestis metabolism could identify metabolic vulnerabilities

  • Determining if SerC is essential for virulence could qualify it as a potential drug target

  • Mapping metabolic changes mediated by SerC during host adaptation could reveal new vaccine targets

• Adjuvant development:

  • If SerC has immunomodulatory properties, it could potentially serve as an adjuvant

  • Understanding metabolic enzyme interactions with host immune systems could inform adjuvant design

  • Recombinant SerC could be co-administered with established vaccine antigens to enhance efficacy

• Comparative approaches with established vaccine strategies:

  • Current research has explored using recombinant Y. pseudotuberculosis strains to deliver Y. pestis antigens like YopE-LcrV fusion proteins

  • Similar approaches could incorporate serC mutations or utilize SerC as part of fusion proteins

  • The attenuated Y. pseudotuberculosis strain χ10069 with Δ yopK Δ yopJ Δ asd triple mutations has shown promise for vaccine delivery

When considering SerC in vaccine development, researchers should note that effective plague vaccines typically target virulence factors rather than metabolic enzymes. The YopE-LcrV fusion delivered by attenuated Y. pseudotuberculosis induced significant protection (80% survival) against intranasal challenge with Y. pestis , setting a benchmark for vaccine efficacy that SerC-based approaches would need to meet or exceed.

What are the current knowledge gaps regarding SerC in Y. pestis bv. Antiqua?

Despite advances in Y. pestis genomics and biochemistry, several knowledge gaps remain regarding SerC in Y. pestis bv. Antiqua:

• Biovar-specific variations: While genomic differences between Y. pestis biovars are documented , the specific variations in SerC sequence, structure, and function between Antiqua and other biovars remain poorly characterized.

• Regulation during infection: How serC expression and SerC activity change during transitions between flea vector and mammalian host environments is not fully understood.

• Contribution to virulence: Whether SerC plays any direct or indirect role in Y. pestis virulence beyond its basic metabolic function remains to be determined.

• Interactions with host metabolism: How SerC-mediated serine metabolism interfaces with host metabolic pathways during infection is largely unexplored.

• Evolutionary selection pressures: The specific evolutionary forces that have shaped SerC in Y. pestis bv. Antiqua compared to other biovars and Y. pseudotuberculosis are not well defined.

Addressing these knowledge gaps would benefit from the multi-omics approaches facilitated by resources like the Yersiniomics platform , which can integrate genomic, transcriptomic, and proteomic data to provide a more comprehensive understanding of SerC in the context of Y. pestis biology.

What future research directions should be prioritized for SerC in Y. pestis bv. Antiqua?

Based on current knowledge and remaining gaps, the following research directions should be prioritized:

• Comparative structural biology:

  • Determine high-resolution structures of SerC from Y. pestis bv. Antiqua and other biovars

  • Compare with Y. pseudotuberculosis SerC to identify structural adaptations

  • Characterize temperature-dependent structural changes relevant to host adaptation

• Systems biology approaches:

  • Map SerC interactions within the broader metabolic network using multi-omics data

  • Identify condition-specific regulation of serC expression and SerC activity

  • Integrate SerC function with host-pathogen interaction models

• Functional genomics:

  • Generate serC mutants to assess its contribution to fitness in different environments

  • Perform complementation studies with serC variants from different biovars

  • Apply CRISPR interference to modulate serC expression and assess phenotypic effects

• Translational applications:

  • Evaluate SerC as a potential drug target based on its metabolic importance

  • Assess biovar-specific SerC features for improved diagnostic applications

  • Explore potential contributions to vaccine development or adjuvant design